UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overview of recent advances in metastatic triple negative breast cancer

World journal of clinical oncology, 2021-03, Vol.12 (3), p.164-182

2021

Volltextzugriff (PDF)

The psychosocial determinants of quality of life in breast cancer survivors: a scoping review

BMC cancer, 2020-10, Vol.20 (1), p.948-948, Article 948

2020

Volltextzugriff (PDF)

Estrogen and HER‐2 Receptor Discordance Between Primary Breast Cancer and Metastasis

The oncologist (Dayton, Ohio), 2010-11, Vol.15 (11), p.1164-1168

2010

Volltextzugriff (PDF)

Cost‐Effectiveness Analysis of Recurrence Score‐Guided Treatment Using a 21‐Gene Assay in Early Breast Cancer

The oncologist (Dayton, Ohio), 2010-05, Vol.15 (5), p.457-465

2010

Volltextzugriff (PDF)

Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor‐positive, HER2‐normal, grade II, lymph node‐negative breast cancers

Cancer, 2010-11, Vol.116 (22), p.5161-5167

2010

Volltextzugriff (PDF)

Subclinical Myocarditis After Combination Immune Checkpoint Inhibitor Therapy

Circulation. Heart failure, 2021-02, Vol.14 (2), p.e007524-e007524

2021

Volltextzugriff (PDF)

Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland

Current oncology (Toronto), 2024-03, Vol.31 (3), p.1302-1310

2024

Volltextzugriff (PDF)

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Breast cancer research : BCR, 2013-09, Vol.15 (5), p.R86-R86, Article R86

2013

Volltextzugriff (PDF)

Conformational dynamics and aggregation behavior of piezoelectric diphenylalanine peptides in an external electric field

Biophysical chemistry, 2015-01, Vol.196, p.16-24

2015

Volltextzugriff (PDF)

Oligometastatic breast cancer: Are we there yet?

International journal of cancer, 2021-10, Vol.149 (8), p.1520-1528

2021

Volltextzugriff (PDF)

Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial

Frontiers in oncology, 2022-09, Vol.12, p.886831-886831

2022

Volltextzugriff (PDF)

Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer

BMC cancer, 2013-04, Vol.13 (1), p.175-175, Article 175

2013

Volltextzugriff (PDF)

“Candidatus Mycoplasma haemomacaque” and Bartonella quintana Bacteremia in Cynomolgus Monkeys

Journal of Clinical Microbiology, 2013-05, Vol.51 (5), p.1408-1411

2013

Volltextzugriff (PDF)

Phase III Trial Evaluating Weekly Paclitaxel Versus Docetaxel in Combination With Capecitabine in Operable Breast Cancer

Journal of clinical oncology, 2012-03, Vol.30 (9), p.930-935

2012

Volltextzugriff (PDF)

Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial

Journal of clinical oncology, 2021-05, Vol.39 (14), p.1518-1530

2021

Volltextzugriff (PDF)

The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer – Trial protocol of a phase II study

Contemporary clinical trials communications, 2021-12, Vol.24, p.100865-100865, Article 100865

2021

Volltextzugriff (PDF)

Spatial predictors of immunotherapy response in triple-negative breast cancer

Nature (London), 2023-09, Vol.621 (7980), p.868-876

2023

Volltextzugriff (PDF)

Competing mortality risks: predicted cardiovascular disease risk versus predicted risk of breast cancer mortality in patients receiving adjuvant chemotherapy in a single Irish center

Cardio-oncology (London, England), 2021-02, Vol.7 (1), p.8-8, Article 8

2021

Volltextzugriff (PDF)

A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast Cancer

Clinical cancer research, 2020-12, Vol.26 (23), p.6149-6157

2020

Volltextzugriff (PDF)

Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer

The oncologist (Dayton, Ohio), 2016-09, Vol.21 (9), p.1063-1078

2016

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy with or without Concurrent Hormone Therapy in Estrogen Receptor-Positive Breast Cancer: NACED-Randomized Multicenter Phase II Trial

Acta medica Okayama, 2015-10, Vol.69 (5), p.291-299

2015

Volltextzugriff (PDF)

Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherence

Supportive care in cancer, 2023-03, Vol.31 (3), p.200-200, Article 200

2023

Volltextzugriff (PDF)

Women’s experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour

Supportive care in cancer, 2015-11, Vol.23 (11), p.3115-3130

2015

Volltextzugriff (PDF)

Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study

European journal of cancer (1990), 2024-01, Vol.196, p.113420-113420, Article 113420

2024

Volltextzugriff (PDF)

1 – 25 von 1.998

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.849)
Mit Volltextzugriff
(1.674)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.985)
Französisch
(10)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(38)
Cancer Research
(27)
Blood
(24)
Plos One
(24)
The Journal Of Pediatrics
(23)
Journal Of Thoracic Oncology
(22)
Scientific Reports
(21)
The New England Journal Of Medicine
(21)
The Lancet
(19)
Biochemical Society Transactions
(14)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(38)
... seit 30 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Overview of recent advances in metastatic triple negative breast cancer

The psychosocial determinants of quality of life in breast cancer survivors: a scoping review

Estrogen and HER‐2 Receptor Discordance Between Primary Breast Cancer and Metastasis

Cost‐Effectiveness Analysis of Recurrence Score‐Guided Treatment Using a 21‐Gene Assay in Early Breast Cancer

Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor‐positive, HER2‐normal, grade II, lymph node‐negative breast cancers

Subclinical Myocarditis After Combination Immune Checkpoint Inhibitor Therapy

Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Conformational dynamics and aggregation behavior of piezoelectric diphenylalanine peptides in an external electric field

Oligometastatic breast cancer: Are we there yet?

Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial

Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer

“Candidatus Mycoplasma haemomacaque” and Bartonella quintana Bacteremia in Cynomolgus Monkeys

Phase III Trial Evaluating Weekly Paclitaxel Versus Docetaxel in Combination With Capecitabine in Operable Breast Cancer

Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial

The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer – Trial protocol of a phase II study

Spatial predictors of immunotherapy response in triple-negative breast cancer

Competing mortality risks: predicted cardiovascular disease risk versus predicted risk of breast cancer mortality in patients receiving adjuvant chemotherapy in a single Irish center

A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast Cancer

Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer

Neoadjuvant Chemotherapy with or without Concurrent Hormone Therapy in Estrogen Receptor-Positive Breast Cancer: NACED-Randomized Multicenter Phase II Trial

Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherence

Women’s experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour

Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study

The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer

Aktive Filter

Suchergebnisse filtern